文献速递白血病淋巴瘤

异常RAG介导的重组促进慢性髓性白血病淋巴系急变中的多发性结构重排

Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia.
PubMed 文献 · Leukemia · 2020-02-19

该研究通过对慢性髓性白血病慢性期(CP,n=49)、髓系急变(MBC,n=19)和淋系急变(LBC,n=20)患者进行全外显子组和/或RNA测序,发现24例急变患者中存在25个局灶性基因缺失和14个融合。LBC中缺失占结构变异的83%,且V(D)J重组相关基因(RAG1/2、DNTT)上调;RAG活性分子标志(DNTT介导的核苷酸插入和RAG结合基序)仅见于高RAG表达患者,LBC中65%患者的结构变异携带这些标志,而MBC仅5%。RAG介导的事件涉及IKZF1、RUNX1、CDKN2A/B和RB1等血液肿瘤相关基因的局灶缺失和新融合;CP诊断时DNTT升高的8/8患者在12个月内进展为LBC,可能有助于早期预测LBC。

要点

  • LBC中结构变异以缺失为主(83%),且RAG1/2和DNTT表达上调。
  • LBC中65%患者结构变异有RAG活性标志,MBC仅5%。
  • CP诊断时DNTT升高者12个月内均进展为LBC(8/8)。

核心结论

  • RAG在LBC中发挥核心致突变作用,其介导的结构变异涉及多个血液肿瘤相关基因。
  • CP诊断时DNTT升高可能早期预测LBC进展。

研究设计与样本

  • 对CP(n=49)、MBC(n=19)和LBC(n=20)患者进行全外显子组和/或RNA测序。

主要发现

  • 24例急变患者中检出25个局灶性基因缺失和14个融合。
  • LBC中缺失占结构变异的83%。
  • LBC中65%患者结构变异携带RAG活性标志,MBC仅5%。
  • RAG介导事件涉及IKZF1、RUNX1、CDKN2A/B和RB1的局灶缺失或新融合。
  • CP诊断时DNTT升高的8/8患者在12个月内进展为LBC。

关键数值与推荐

  • RAG活性分子标志包括DNTT介导的核苷酸插入和结构变异处的RAG结合基序。

临床怎么用

  • CP诊断时检测DNTT表达可能有助于早期识别LBC高危患者。
  • RAG介导的结构变异特征可为CML急变机制评估提供信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Blast crisis of chronic myeloid leukemia is associated with poor survival and the accumulation of genomic lesions. Using whole-exome and/or RNA sequencing of patients at chronic phase (CP, n = 49), myeloid blast crisis (MBC, n = 19), and lymphoid blast crisis (LBC, n = 20), we found 25 focal gene deletions and 14 fusions in 24 patients in BC. Deletions predominated in LBC (83% of structural variants). Transcriptional analysis identified the upregulation of genes involved in V(D)J recombination, including RAG1/2 and DNTT in LBC. RAG recombination is a reported mediator of IKZF1 deletion. We investigated the extent of RAG-mediated genomic lesions in BC. Molecular hallmarks of RAG activity; DNTT-mediated nucleotide insertions and a RAG-binding motif at structural variants were exclusively found in patients with high RAG expression. Structural variants in 65% of patients in LBC displayed these hallmarks compared with only 5% in MBC. RAG-mediated events included focal deletion and novel fusion of genes associated with hematologic cancer: IKZF1, RUNX1, CDKN2A/B, and RB1. Importantly, 8/8 patients with elevated DNTT at CP diagnosis progressed to LBC by 12 months, potentially enabling early prediction of LBC. This work confirms the central mutagenic role of RAG in LBC and describes potential clinical utility in CML management.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Thomson DW, Shahrin NH, Wang PPS, et al. Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia. Leukemia. 2020. PMID: 32076119. doi:10.1038/s41375-020-0751-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。